Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat

T. J. Cicero, A. Aleem, E. R. Meyer, P. F. Schmoeker, B. T. Miller

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    In previous studies, it was demonstrated that morphine pellet implantation markedly sensitized adult male rats to the subsequent elevations in serum luteinizing hormone (LH) levels produced by the opiate antagonist, naloxone. The present studies were carried out to examine the persistence of this phenomenon upon pellet removal and to characterize the relationship between naloxone-induced alterations in serum LH and the development and dissipation of precipitated withdrawal behavior. We found an excellent correlation between both the development and dissipation of naloxone-precipitated withdrawal behavior and hypersensitivity to naloxone's effects on serum LH. However, although there was no evidence of protracted effects of chronic morphine administration upon pellet removal as assessed by withdrawal behavior, the effects of naloxone on serum LH levels did not return to normal for nearly a week postwithdrawal. The markedly enhanced sensitivity to naloxone normally observed in the pellet-implanted animal dissipated immediately after pellet removal (6-24 hr), but, rather than exhibiting normal levels of responding, morphine-withdrawn animals were markedly hyposensitive to naloxone. The antagonist did not increase LH at all in pellet-withdrawn animals and, in fact, appeared to depress them at many doses in the acutely withdrawn animal; normal responses did not return until 4 to 7 days after pellet removal. The mechanisms underlying the striking withdrawal-induced reversal of naloxone's effects on serum LH levels are presently unclear, but our data are consistent with the hypothesis that chronic morphine administration induces a fundamental change in the sensitivity of the endogenous opioid-mediated control of LH, which takes some time to revert to normal upon abrupt termination of opiate administration.

    Original languageEnglish (US)
    Pages (from-to)1063-1070
    Number of pages8
    JournalJournal of Pharmacology and Experimental Therapeutics
    Volume238
    Issue number3
    StatePublished - 1986

    Fingerprint

    Opiate Alkaloids
    Naloxone
    Luteinizing Hormone
    Serum
    Morphine
    Opioid Analgesics
    Hypersensitivity

    ASJC Scopus subject areas

    • Pharmacology

    Cite this

    Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat. / Cicero, T. J.; Aleem, A.; Meyer, E. R.; Schmoeker, P. F.; Miller, B. T.

    In: Journal of Pharmacology and Experimental Therapeutics, Vol. 238, No. 3, 1986, p. 1063-1070.

    Research output: Contribution to journalArticle

    Cicero, T. J. ; Aleem, A. ; Meyer, E. R. ; Schmoeker, P. F. ; Miller, B. T. / Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat. In: Journal of Pharmacology and Experimental Therapeutics. 1986 ; Vol. 238, No. 3. pp. 1063-1070.
    @article{ce29f81f033e4c0f944b12cb696fd63f,
    title = "Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat",
    abstract = "In previous studies, it was demonstrated that morphine pellet implantation markedly sensitized adult male rats to the subsequent elevations in serum luteinizing hormone (LH) levels produced by the opiate antagonist, naloxone. The present studies were carried out to examine the persistence of this phenomenon upon pellet removal and to characterize the relationship between naloxone-induced alterations in serum LH and the development and dissipation of precipitated withdrawal behavior. We found an excellent correlation between both the development and dissipation of naloxone-precipitated withdrawal behavior and hypersensitivity to naloxone's effects on serum LH. However, although there was no evidence of protracted effects of chronic morphine administration upon pellet removal as assessed by withdrawal behavior, the effects of naloxone on serum LH levels did not return to normal for nearly a week postwithdrawal. The markedly enhanced sensitivity to naloxone normally observed in the pellet-implanted animal dissipated immediately after pellet removal (6-24 hr), but, rather than exhibiting normal levels of responding, morphine-withdrawn animals were markedly hyposensitive to naloxone. The antagonist did not increase LH at all in pellet-withdrawn animals and, in fact, appeared to depress them at many doses in the acutely withdrawn animal; normal responses did not return until 4 to 7 days after pellet removal. The mechanisms underlying the striking withdrawal-induced reversal of naloxone's effects on serum LH levels are presently unclear, but our data are consistent with the hypothesis that chronic morphine administration induces a fundamental change in the sensitivity of the endogenous opioid-mediated control of LH, which takes some time to revert to normal upon abrupt termination of opiate administration.",
    author = "Cicero, {T. J.} and A. Aleem and Meyer, {E. R.} and Schmoeker, {P. F.} and Miller, {B. T.}",
    year = "1986",
    language = "English (US)",
    volume = "238",
    pages = "1063--1070",
    journal = "Journal of Pharmacology and Experimental Therapeutics",
    issn = "0022-3565",
    publisher = "American Society for Pharmacology and Experimental Therapeutics",
    number = "3",

    }

    TY - JOUR

    T1 - Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat

    AU - Cicero, T. J.

    AU - Aleem, A.

    AU - Meyer, E. R.

    AU - Schmoeker, P. F.

    AU - Miller, B. T.

    PY - 1986

    Y1 - 1986

    N2 - In previous studies, it was demonstrated that morphine pellet implantation markedly sensitized adult male rats to the subsequent elevations in serum luteinizing hormone (LH) levels produced by the opiate antagonist, naloxone. The present studies were carried out to examine the persistence of this phenomenon upon pellet removal and to characterize the relationship between naloxone-induced alterations in serum LH and the development and dissipation of precipitated withdrawal behavior. We found an excellent correlation between both the development and dissipation of naloxone-precipitated withdrawal behavior and hypersensitivity to naloxone's effects on serum LH. However, although there was no evidence of protracted effects of chronic morphine administration upon pellet removal as assessed by withdrawal behavior, the effects of naloxone on serum LH levels did not return to normal for nearly a week postwithdrawal. The markedly enhanced sensitivity to naloxone normally observed in the pellet-implanted animal dissipated immediately after pellet removal (6-24 hr), but, rather than exhibiting normal levels of responding, morphine-withdrawn animals were markedly hyposensitive to naloxone. The antagonist did not increase LH at all in pellet-withdrawn animals and, in fact, appeared to depress them at many doses in the acutely withdrawn animal; normal responses did not return until 4 to 7 days after pellet removal. The mechanisms underlying the striking withdrawal-induced reversal of naloxone's effects on serum LH levels are presently unclear, but our data are consistent with the hypothesis that chronic morphine administration induces a fundamental change in the sensitivity of the endogenous opioid-mediated control of LH, which takes some time to revert to normal upon abrupt termination of opiate administration.

    AB - In previous studies, it was demonstrated that morphine pellet implantation markedly sensitized adult male rats to the subsequent elevations in serum luteinizing hormone (LH) levels produced by the opiate antagonist, naloxone. The present studies were carried out to examine the persistence of this phenomenon upon pellet removal and to characterize the relationship between naloxone-induced alterations in serum LH and the development and dissipation of precipitated withdrawal behavior. We found an excellent correlation between both the development and dissipation of naloxone-precipitated withdrawal behavior and hypersensitivity to naloxone's effects on serum LH. However, although there was no evidence of protracted effects of chronic morphine administration upon pellet removal as assessed by withdrawal behavior, the effects of naloxone on serum LH levels did not return to normal for nearly a week postwithdrawal. The markedly enhanced sensitivity to naloxone normally observed in the pellet-implanted animal dissipated immediately after pellet removal (6-24 hr), but, rather than exhibiting normal levels of responding, morphine-withdrawn animals were markedly hyposensitive to naloxone. The antagonist did not increase LH at all in pellet-withdrawn animals and, in fact, appeared to depress them at many doses in the acutely withdrawn animal; normal responses did not return until 4 to 7 days after pellet removal. The mechanisms underlying the striking withdrawal-induced reversal of naloxone's effects on serum LH levels are presently unclear, but our data are consistent with the hypothesis that chronic morphine administration induces a fundamental change in the sensitivity of the endogenous opioid-mediated control of LH, which takes some time to revert to normal upon abrupt termination of opiate administration.

    UR - http://www.scopus.com/inward/record.url?scp=0022501342&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0022501342&partnerID=8YFLogxK

    M3 - Article

    VL - 238

    SP - 1063

    EP - 1070

    JO - Journal of Pharmacology and Experimental Therapeutics

    JF - Journal of Pharmacology and Experimental Therapeutics

    SN - 0022-3565

    IS - 3

    ER -